PROM1 and metabolic dysfunction-associated steatohepatitis: NAFLD is characterized by triglyceride accumulation in the cytoplasm of hepatocytes and measurement of hepatic triglycerides and free fatty acids as well as evaluation of the therapeutic effects of CD133 + Exo in a T2DM only model and NASH only model is warranted.